Researcher Spotlight: Elise A. Chong, MD University of Pennsylvania Perelman School of Medicine Chimeric antigen receptor (CAR) T-cell therapy has been an effective treatment for any patients with B-cell lymphomas who don’t respond to other therapies, producing remissions in 30…
Researcher Spotlight: Jianguo Tao, MD, PhD H. Lee Moffitt Cancer Center With the success of ibrutinib in mantle cell lymphoma (MCL) and other B-cell lymphomas, researchers have become focused on the problem of treatment resistance – not only do a…
Researcher Spotlight: Sandeep Dave, MD, MS Duke University Medical Center “Even as progress has been made in a number of cancers, the options for MCL patients remain disappointingly narrow,” says Dr. Dave. He and his colleagues are seeking to expand…
Researcher Spotlight: Selina Chen-Kiang, PhD Weill Cornell Lymphoma Research Foundation (LRF)- supported research may have identified both the molecular mechanism that causes some mantle cell lymphoma (MCL) patients to be resistant to ibrutinib (Imbruvica), and ways to overcome that resistance.…
Researcher Spotlight: Elias Campo, MD, PhD Hospital Clinic of the University of Barcelona in Spain Dr. Campo is Research Director and Professor of Anatomic Pathology at the Hospital Clinic of the University of Barcelona in Spain. He and his colleagues…
Researcher Spotlight: John P. Leonard, MD Weill Cornell Medicine Chemotherapy is an effective strategy in treating many lymphoma patients, however, its toxicity and the growing number of effective novel therapies for lymphoma has prompted researchers to explore chemotherapy-free options…
Researcher Spotlight: Craig Portell, MD University of Virginia Dr. Portell, an Assistant Professor of Medicine at the University of Virginia (UVA), joined UVA’s faculty in order to work with Dr. Michael E. Williams, a Lymphoma Research Foundation (LRF) Scientific…
Researcher Spotlight: Danielle Brander, MD Duke University Dr. Brander is a second year faculty member in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. Her interests as a research clinician are improving and developing novel therapies…
Researcher Spotlight: Jianguo Tao, MD, PhD H. Lee Moffitt Cancer and Research Institute Though available therapies for lymphoma are becoming increasingly effective at slowing disease progression and prompting remissions, many patients eventually develop drug resistance that allows their disease…
Researcher Spotlight: Andre Goy, MD, MS John Theurer Cancer Center Dr. Goy is the Chairman and Director of the John Theurer Cancer Center in Hackensack, NJ, where he is also Chief of the Division of Lymphoma. At John Theurer,…
